Human PLA2G7, recombinant

Human PLA2G7, recombinant
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NOV-DC624.50ug 50 µg - -

Fragen Sie uns nach der Lieferzeit

57,00 €
NOV-DC624.500ug 500 µg - -

Fragen Sie uns nach der Lieferzeit

400,00 €
NOV-DC624.1mg 1 mg - -

Fragen Sie uns nach der Lieferzeit

600,00 €
 
Recombinant Human Proteinase 3/PRTN3/Myeloblastin (C-6His) is produced by Mammalian expression... mehr
Produktinformationen "Human PLA2G7, recombinant"
Recombinant Human Proteinase 3/PRTN3/Myeloblastin (C-6His) is produced by Mammalian expression system and the target gene is expressed with a 6His tag at the C-terminus. Protein function: Lipoprotein-associated calcium-independent phospholipase A2 involved in phospholipid catabolism during inflammatory and oxidative stress response (PubMed:7700381, PubMed:8624782, PubMed:2040620, PubMed:16371369, PubMed:17090529, PubMed:10066756). At the lipid- aqueous interface, hydrolyzes the ester bond of fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) (PubMed:2040620, PubMed:10504265). Specifically targets phospholipids with a short-chain fatty acyl group at sn-2 position (PubMed:2040620). Can hydrolyze phospholipids with long fatty acyl chains, only if they carry oxidized functional groups (PubMed:2040620, PubMed:8624782). Hydrolyzes and inactivates platelet-activating factor (PAF, 1-O-alkyl- 2-acetyl-sn-glycero-3-phosphocholine), a potent proinflammatory signaling lipid that acts through PTAFR on various innate immune cells (PubMed:10504265, PubMed:10066756, PubMed:7592717, PubMed:11590221, PubMed:7700381, PubMed:18434304, PubMed:16371369, PubMed:8675689, PubMed:8624782). Hydrolyzes oxidatively truncated phospholipids carrying an aldehyde group at omega position, preventing their accumulation in low-density lipoprotein (LDL) particles and uncontrolled proinflammatory effects (PubMed:2040620, PubMed:7700381). As part of high-density lipoprotein (HDL) particles, can hydrolyze phospholipids having long-chain fatty acyl hydroperoxides at sn-2 position and protect against potential accumulation of these oxylipins in the vascular wall (PubMed:17090529). Catalyzes the release from membrane phospholipids of F2-isoprostanes, lipid biomarkers of cellular oxidative damage (PubMed:16371369). [The UniProt Consortium]
Schlagworte: PAFAH, PLA2G7, gVIIA-PLA2, LDL-PLA(2), PAF 2-acylhydrolase, PAF acetylhydrolase, Group-VIIA phospholipase A2, LDL-associated phospholipase A2, Platelet-activating factor acetylhydrolase, 2-acetyl-1-alkylglycerophosphocholine esterase, Recombinant Human PL
Hersteller: Novoprotein
Hersteller-Nr: DC624

Eigenschaften

Konjugat: No
Wirt: Human cells
Spezies-Reaktivität: human
MW: 48.8 kD
Format: Solution

Datenbank Information

KEGG ID : K01062 | Passende Produkte
UniProt ID : Q13093 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Human PLA2G7, recombinant"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen